glp 1 cost hers Hims & swings to a loss in Q1 amid shift in GLP-1 strategy Health Agency Refers Knockoff GLP-1
Description
202201011395 to X.L
Clinical trials have demonstrated varying efficacy across the class, with weight reductions ranging from approximately 5-8% with liraglutide 3 mg to 15% with semaglutide 2.4 mg and 10-22% with tirzepatide, depending on dose
In summary, exenatide was a trailblazer
[DOI] [PubMed] [Google Scholar] 36.Fonseca VA, Devries JH, Henry RR, Donsmark M, Thomsen HF, Plutzky J
